Role of toll interleukin-1 receptor (IL-1R) 8, a negative regulator of il-1r/toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 100-109

  Rodriguez, Tania Véliz ^a,b   Moalli, Federica ^a   Polentarutti, Nadia ^a   Paroni, Moira ^b,e   Bonavita, Eduardo ^a   Anselmo, Achille ^a   Nebuloni, Manuela ^c   Mantero, Stefano ^a   Jaillon, Sébastien ^a   Bragonzi, Alessandra ^b   Mantovani, Alberto ^a,d   Riva, Federica ^d   Garlanda, Cecilia ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL INTERLEUKIN 1 RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; TIR8 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFECTION RESISTANCE; INFECTION RISK; INNATE IMMUNITY; LUNG INFECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS INFECTION; SURVIVAL RATE; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; CYTOCHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PSEUDOMONAS AERUGINOSA; SECRETION; SIGNAL TRANSDUCTION; SURVIVAL;

ANIMALS; BACTERIAL LOAD; CYTOKINES; HISTOCYTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84857098277     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05695-11     Document Type: Article

References (64)

1. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1β and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949.
2. Alves-Filho JC, et al. 2009. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. U. S. A. 106:4018-4023.
3. Bekker LG, et al. 2000. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 68:6954-6961.
4. Belladonna ML, et al. 2006. IL-23 neutralization protects mice from Gram-negative endotoxic shock. Cytokine 34:161-169.
5. Bomberger JM, et al. 2011. A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog. 7:e1001325.
6. Bozza S, et al. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180:4022-4031.
7. Bragonzi A, et al. 2009. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180:138-145.
8. Bulek K, et al. 2009. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J. Immunol. 182:2601-2609.
9. Chen SM, et al. 2008. The nuclear factor kappa-B pathway in airway epithelium regulates neutrophil recruitment and host defence following Pseudomonas aeruginosa infection. Clin. Exp. Immunol. 153:420-428.
10. Cigana C, et al. 2009. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS One 4:e8439.
11. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550.
12. Dubin PJ, Kolls JK. 2007. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L519-L528.
13. 12a.European Economic Community. 1987. EEC Council Directive 86/609, OJ L 358,1, 12 December 1987, on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. European Economic Community, Brussels, Belgium.
14. Franchi L, et al. 2007. Critical role for Ipaf in Pseudomonas aeruginosainduced caspase-1 activation. Eur. J. Immunol. 37:3030-3039.
15. Garlanda C, Anders HJ, Mantovani A. 2009. TIR8/SIGIRR: an IL-1R/ TLR family member with regulatory functions in inflammation and T cell polarization. Trends Immunol. 30:439-446.
16. Garlanda C, et al. 2007. Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J. Immunol. 179:3119-3125.
17. Garlanda C, et al. 2004. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. U. S. A. 101:3522-3526.
18. Garlanda C, et al. 2007. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67:6017-6021.
19. Gomez MI, Prince A. 2007. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 7:244-251.
20. Grassme H, et al. 2003. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 9:322-330.
21. Grassme H, et al. 2006. Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1. Cell Microbiol. 8:1096-1105.
22. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
23. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7:654-665.
24. Hauser AR, et al. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
25. Hedayat M, Netea MG, Rezaei N. 2011. Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect. Dis. 11:702-712.
26. Huang X, Hazlett LD, Du W, Barrett RP. 2006. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J. Immunol. 177:548-556.
27. (a)Italian Ministry of Health. 1992. Guidelines for the ethical use of animals. Decreto Legislativo 4, n. 116. Gazzetta Ufficiale 40(Suppl):18 February 1992.
28. Juffermans NP, et al. 2000. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182:902-908.
29. Kurahashi K, et al. 1999. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 104:743-750.
30. Lech M, et al. 2009. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J. Immunol. 183:4109-4118.
31. Lech M, et al. 2008. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J. Exp. Med. 205:1879-1888.
32. Liew FY, Xu D, Brint EK, O'Neill LA. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-458.
33. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
34. Navarini AA, et al. 2009. Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc. Natl. Acad. Sci. U. S. A. 106:7107-7112.
35. Noris M, et al. 2009. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J. Immunol. 183:4249-4260.
36. Park H, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
37. Polentarutti N, et al. 2003. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur. Cytokine Netw. 14:211-218.
38. Power MR, Peng Y, Maydanski E, Marshall JS, Lin TJ. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279:49315-49322.
39. Qin J, Qian Y, Yao J, Grace C, Li X. 2005. SIGIRR inhibits interleukin-1 receptor-and Toll-like receptor 4-mediated signaling through different mechanisms. J. Biol. Chem. 280:25233-25241.
40. Ramphal R, Balloy V, Huerre M, Si-Tahar M, Chignard M. 2005. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J. Immunol. 175:3927-3934.
41. Ramphal R, et al. 2008. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 181:586-592.
42. Raoust E, et al. 2009. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One 4:e7259.
43. Reiniger N, et al. 2007. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun. 75:1598-1608.
44. Roach DR, et al. 2001. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J. Exp. Med. 193:239-246.
45. Roger T, Calandra T. 2009. TLR2-mediated neutrophil depletion exacerbates bacterial sepsis. Proc. Natl. Acad. Sci. U. S. A. 106:6889-6890.
46. Roger T, et al. 2009. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 106:2348-2352.
47. Roy-Burman A, et al. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
48. Sadikot RT, Blackwell TS, Christman JW, Prince AS. 2005. Pathogenhost interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171:1209-1223.
49. Sawa T, et al. 1997. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 159:2858-2866.
50. Schultz MJ, et al. 2003. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect. Immun. 71:1630-1634.
51. Schultz MJ, et al. 2002. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L285-290.
52. Schultz MJ, Rijneveld AW, Speelman P, van Deventer SJ, van der Poll T. 2001. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia. Eur. Cytokine Netw. 12:39-44.
53. Sims JE, Smith DE. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10:89-102.
54. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. 2004. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J. Immunol. 172:3377-3381.
55. Skerrett SJ, et al. 1999. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am. J. Physiol. 276:L715-L727.
56. Stover CK, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
57. Sutterwala FS, et al. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204:3235-3245.
58. Teichgraber V, et al. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14:382-391.
59. Thomassen E, Renshaw BR, Sims JE. 1999. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11:389-399.
60. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. 2011. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 32:110-116.
61. Wald D, et al. 2003. SIGIRR, a negative regulator of Toll-like receptorinterleukin 1 receptor signaling. Nat. Immunol. 4:920-927.
62. Wangdi T, Mijares LA, Kazmierczak BI. 2010. In vivo discrimination of type 3 secretion system-positive and-negative Pseudomonas aeruginosa via a caspase-1-dependent pathway. Infect. Immun. 78:4744-4753.
63. Wieland CW, et al. 2002. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. Infect. Immun. 70:1352-1358.
64. Zelante T, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695-2706.